Korean National Cancer Screening Program Reduces Colorectal Cancer Mortality
Author Information
Author(s): Lee Hyeon Ji, Lee Kyeongmin, Kim Byung Chang, Jun Jae Kwan, Choi Kui Son, Suh Mina
Primary Institution: National Cancer Center, Korea
Hypothesis
Does colorectal cancer screening with a fecal immunochemical test reduce mortality?
Conclusion
The study found that colorectal cancer screening using FIT significantly reduces mortality among individuals aged 50 to 74 years.
Supporting Evidence
- Screening reduced colorectal cancer-specific mortality by 26%.
- More screenings led to lower mortality rates.
- Results were significant for individuals aged 50-74 years.
Takeaway
Getting tested for colorectal cancer can help save lives, especially for people between 50 and 74 years old.
Methodology
A nested case-control study using cohort data from the Korean National Cancer Screening Program database.
Potential Biases
Self-selection bias may have led to an overestimation of screening effectiveness.
Limitations
The study design was observational, which may introduce biases such as self-selection and lead-time bias.
Participant Demographics
Participants were colorectal cancer-free individuals aged 50 years and older.
Statistical Information
P-Value
0.74
Confidence Interval
0.71–0.76
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website